ORIC Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.4%.

Top 25 shareholders own 84.24% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.98%	Pfizer Inc.	5,376,344	US$47.2m	0%	no data
7.56%	FMR LLC	5,094,729	US$44.7m	-27.2%	no data
6.57%	VR Adviser, LLC	4,428,385	US$38.8m	82.4%	2.3%
6.36%	Nextech Invest Ltd.	4,285,714	US$37.6m	0%	7.22%
6.15%	Frazier Life Sciences Management, LP	4,142,855	US$36.3m	93.3%	1.82%
5.94%	Viking Global Investors LP	4,000,000	US$35.1m	0%	0.14%
5.3%	The Column Group, LLC	3,568,181	US$31.3m	0%	20.36%
5.07%	EcoR1 Capital, LLC	3,418,068	US$30.0m	0%	1.01%
4.45%	Alkeon Capital Management, LLC	3,001,241	US$26.3m	3.09%	0.22%
4.45%	BlackRock, Inc.	2,995,032	US$26.3m	-3.25%	no data
3.34%	The Vanguard Group, Inc.	2,252,519	US$19.8m	-13%	no data
2.57%	ArrowMark Colorado Holdings, LLC	1,733,819	US$15.2m	5.08%	0.19%
2.57%	Tavistock Life Sciences	1,732,571	US$15.2m	0%	0.98%
2.34%	Prosight Management, LP	1,578,263	US$13.8m	-38.8%	6.4%
1.74%	Silverarc Capital Management, LLC	1,170,000	US$10.3m	4.15%	3.28%
1.5%	Invus Financial Advisors, LLC	1,007,575	US$8.8m	0%	7.84%
1.47%	Euclidean Capital LLC	989,410	US$8.7m	0%	0.98%
1.3%	Geode Capital Management, LLC	874,891	US$7.7m	6.64%	no data
1.26%	Vivo Capital, LLC	849,681	US$7.5m	9.22%	0.63%
1.18%	State Street Global Advisors, Inc.	793,074	US$7.0m	10.3%	no data
1.11%	Franklin Resources, Inc.	750,336	US$6.6m	0%	no data
1.08%	Jacob Chacko	728,544	US$6.4m	-9.89%	no data
1%	Altium Capital Management LP	676,000	US$5.9m	61.5%	3.51%
0.98%	Janus Henderson Group plc	659,054	US$5.8m	0%	no data
0.97%	T. Rowe Price Group, Inc.	651,561	US$5.7m	1,340%	no data